MedTrace Logo

Integrative Treatment Methods in COVID-19

NCT05089578 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12

Last updated 2021-10-22

No results posted yet for this study

Summary

This study was conducted to examine the use of integrative treatment methods by individuals undergoing Covid-19. In this study, which was designed in the qualitative and phenomenological type, the criterion sampling method was used and 12 people were included in the sample.

Conditions

  • COVID-19
  • Patient Experience
  • Health Attitude

Interventions

OTHER

focus interview

The "Information Form" including descriptive characteristics of the individuals undergoing Covid-19, the semi-structured "Interview Form", and the Complementary Therapy Use Form were used as the data collection tools. The Information Form consisted of 13 questions including socio-demographic and disease-related characteristics of individuals. In-depth interview method was used to collect data. Interviews were held by organizing video calls and online meeting programs on mobile phones both due to pandemic measures and in order to enable individuals to communicate comfortably. The time period in which the individuals felt most ready for the interview was determined and the data were collected during that time. During the interview, effective communication techniques were used, active listening was carried out and individuals were guided using question forms in accordance with the aim of the study. The interviews lasted for an average of 25-30 minutes.

Sponsors & Collaborators

  • Amasya University

    lead OTHER

Principal Investigators

  • Gamze Fıskın, PhD · Amasya University

  • Nurhan Dogan, PhD · Amasya University

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-07-15
Primary Completion
2021-10-15
Completion
2021-10-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05089578 on ClinicalTrials.gov